Quarterly report [Sections 13 or 15(d)]

Statements of Cash Flows (Unaudited)

v3.25.3
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:              
Net loss $ (1,691,989) $ (2,303,587) $ (3,173,156) $ (3,134,262) $ (5,696,669) $ (9,136,523)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock-based compensation 37,840   20,992   114,263 627,834  
Increase (decrease) in cash resulting from changes in:              
Prepaid expenses and other current assets         (34,965) (3,095)  
Accounts payable         (304,089) (10,324)  
Accrued and other current liabilities         (506,902) 272,774  
Total adjustments to reconcile net loss to net cash used in operations         (731,693) 887,189  
Net cash used in operating activities         (6,428,362) (8,249,334) $ (11,100,000)
Cash flows from financing activities:              
Proceeds from issuance of Common Stock and warrants, net of issuance costs         7,980,804 6,955,611  
Payment of prior period issuance costs         (50,495)  
Proceeds from exercise of pre-funded warrants         977 168  
Payment for fractional shares in reverse stock split         (367) (828)  
Net cash provided by financing activities         7,930,919 6,954,951  
Net increase (decrease) in cash and cash equivalents         1,502,557 (1,294,383)  
Cash and cash equivalents at beginning of period   $ 3,161,570   $ 7,438,135 3,161,570 7,438,135 7,438,135
Cash and cash equivalents at end of period $ 4,664,127   $ 6,143,752   4,664,127 6,143,752 $ 3,161,570
Non-cash financing activities:              
Issuance of abeyance shares         (24) (5)  
Issuance costs in accounts payable or accrued expenses         60,051  
Supplemental disclosure:              
Cash paid for taxes         $ 950 $ 950